abstract |
The present invention has the following formula (I) suitable for the treatment of diseases having tubulin inhibitory activity and characterized by excessive or abnormal cell proliferation. [Chemical 1] (Wherein A, T and R 1 to R 3 are as defined in claim 1) relates to the use of the pyrrolobenzimidazolone compounds and their pharmaceutical compositions. [Selection figure] None |